Twirla

Agile Therapeutics, Inc.🇺🇸 United States

FDA Page

Effective Date: Jun 30, 2026
Approval ID: bcaf8db0-1750-425d-b008-255b5e7a9cc6
Products: 1 registered
Version: 9

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use TWIRLA safely and effectively. See full prescribing information for TWIRLA. TWIRLA (levonorgestrel and ethinyl estradiol) transdermal system Initial U.S. Approval: 1968 (norgestrel and ethinyl estradiol)

Quick Stats

Total Products1

Labelers1

Label Sections23

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.